Tema Oncology ETF (CANC)
NASDAQ: CANC · Real-Time Price · USD
25.93
+0.03 (0.10%)
Aug 1, 2025, 4:00 PM - Market closed

CANC Holdings Information

CANC is an equity ETF with a total of 52 individual holdings. The top holdings are Roche Holding AG stock at 4.90%, Revolution Medicines at 4.59%, Eli Lilly and Company at 4.46%, Merus at 4.46%, and BridgeBio Pharma at 4.41%.

Total Holdings
52
Top 10 Percentage
42.01%
Asset Class
Equity
ETF Category
Health
Assets
69.02M
PE Ratio
20.39

Sector Allocation

Top 25 Holdings

No.SymbolName WeightShares
1RHHBYRoche Holding AG4.90%83,774
2RVMDRevolution Medicines, Inc.4.59%84,831
3LLYEli Lilly and Company4.46%4,014
4MRUSMerus N.V.4.46%46,111
5BBIOBridgeBio Pharma, Inc.4.41%66,136
6LON: AZNAstraZeneca PLC4.23%18,997
7SWX: NOVNNovartis AG4.05%23,707
8GMABGenmab A/S3.81%117,196
9SMMTSummit Therapeutics Inc.3.75%96,271
10AMGNAmgen Inc.3.36%7,621
11NUVLNuvalent, Inc.3.32%28,601
12ZLABZai Lab Limited3.27%58,071
13BMYBristol-Myers Squibb Company3.25%48,436
14EXELExelixis, Inc.3.23%59,974
15ACLXArcellx, Inc.3.19%30,505
16ONCBeOne Medicines Ltd.3.05%6,953
17LEGNLegend Biotech Corporation3.01%51,033
18MRKMerck & Co., Inc.2.48%20,728
19IDYAIDEAYA Biosciences, Inc.2.32%62,734
20ABBVAbbVie Inc.2.15%7,764
21TYO: 4568Daiichi Sankyo Company, Limited1.83%51,095
22IMNMImmunome, Inc.1.63%103,889
23JANXJanux Therapeutics, Inc.1.60%45,077
24COGTCogent Biosciences, Inc.1.42%84,127
25GILDGilead Sciences, Inc.1.39%8,264
As of Jul 30, 2025
Showing 25 of 52
Subscribe to see the full list